Previous studies have also shown serum CK-18 fragment levels correlated positively with the severity of hepatic inflammation and hepatocyte apoptosis associated with NASH [11,50–54]. This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatohepatitis.